Last reviewed · How we verify
HeXell-2020 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HeXell-2020 (HeXell-2020) — Hexun Biosciences Co., LTD..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HeXell-2020 TARGET | HeXell-2020 | Hexun Biosciences Co., LTD. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HeXell-2020 CI watch — RSS
- HeXell-2020 CI watch — Atom
- HeXell-2020 CI watch — JSON
- HeXell-2020 alone — RSS
Cite this brief
Drug Landscape (2026). HeXell-2020 — Competitive Intelligence Brief. https://druglandscape.com/ci/hexell-2020. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab